Literature DB >> 15895356

Use of percutaneous endoscopic gastrostomy feeding tubes and functional recovery in stroke rehabilitation: a case-matched controlled study.

Masayuki Iizuka1, Mike Reding.   

Abstract

OBJECTIVE: To compare the morbidity, mortality, and functional recovery of patients who require percutaneous endoscopic gastrostomy (PEG) placement for the management of dysphagia after stroke.
DESIGN: Retrospective case-matched controlled study.
SETTING: Acute stroke rehabilitation inpatient unit. PARTICIPANTS: Patients (N=193) who were admitted for stroke rehabilitation with a PEG tube in place from January 1, 1993, to December 31, 2002, were matched with 193 case controls without PEG. Patients and controls were within 90 days of stroke onset, and were matched for age, sex, type of stroke, FIM instrument score, duration from onset to stroke unit admission, and year of admission.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Length of rehabilitation hospital stay, improvement in FIM scores, FIM efficiency score, need for transfer back to acute care hospital, diagnosis for which transfer was required, final discharge destination, and survival status.
RESULTS: Significant differences were found between the 2 groups, PEG versus control, respectively, in the following variables: FIM efficiency (.42+/-.57 vs .56+/-.55, P =.016); need for transfer back to acute hospital (58/193 vs 23/193, P =.001); and survival status dead/alive (14/179 vs 3/190, P =.006). Nonsignificant differences were as follows: length of rehabilitation hospital stay (46.9+/-24.8d vs 43.3+/-19.7d, P =.11), improvement in total FIM score from admission to discharge (16.9+/-17.9 vs 21.0+/-15.5, P =.72), and final discharge destination home/institutional care (96/83 vs 101/89, P =.93). Pneumonia was the most frequent reason for transfer to acute care for patients with PEG.
CONCLUSIONS: Patients who meet criteria for admission to a stroke rehabilitation unit and who have a PEG in place are at increased risk for medical complications and death. Those who survive, however, show similar functional recovery and rate of home discharge as case-matched controls.

Entities:  

Mesh:

Year:  2005        PMID: 15895356     DOI: 10.1016/j.apmr.2004.09.021

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

1.  Indications, complications and long-term follow-up of patients undergoing percutaneous endoscopic gastrostomy: A retrospective study.

Authors:  Fatih Ermis; Melih Ozel; Kemal Oncu; Yusuf Yazgan; Levent Demirturk; Ahmet Kemal Gurbuz; Taner Akyol; Hasan Nazik
Journal:  Wien Klin Wochenschr       Date:  2012-03-05       Impact factor: 1.704

2.  Race Differences in Gastrostomy Tube Placement After Stroke in Majority-White, Minority-Serving, and Racially Integrated US Hospitals.

Authors:  Roland Faigle; Lisa A Cooper; Rebecca F Gottesman
Journal:  Dysphagia       Date:  2018-02-21       Impact factor: 3.438

3.  Long-term survival in older critically ill patients with acute ischemic stroke.

Authors:  Ellie Golestanian; Jinn-Ing Liou; Maureen A Smith
Journal:  Crit Care Med       Date:  2009-12       Impact factor: 7.598

4.  Racial and Socioeconomic Disparities in Gastrostomy Tube Placement After Intracerebral Hemorrhage in the United States.

Authors:  Roland Faigle; Mona N Bahouth; Victor C Urrutia; Rebecca F Gottesman
Journal:  Stroke       Date:  2016-02-18       Impact factor: 7.914

5.  Acceptability and outcomes of the Percutaneous Endoscopic Gastrostomy (PEG) tube placement--patients' and care givers' perspectives.

Authors:  Muhammad K Anis; Shahab Abid; Wasim Jafri; Zaigham Abbas; Hasnain A Shah; Saeed Hamid; Rozina Wasaya
Journal:  BMC Gastroenterol       Date:  2006-11-24       Impact factor: 3.067

6.  Factors predicting early discharge and mortality in post-percutaneous endoscopic gastrostomy patients.

Authors:  Vivek V Gumaste; Kalyan R Bhamidimarri; Raghav Bansal; Lovleen Sidhu; Joel Baum; Aaron Walfish
Journal:  Ann Gastroenterol       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.